Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-13-013730
Filing Date
2013-03-22
Accepted
2013-03-22 16:14:39
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICALS INC 10-K 12-31-2012 form10k.htm 10-K 2284363
2 EXHIBIT 23 ex23.htm EX-23 3150
3 EXHIBIT 24 ex24.htm EX-24 33434
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 15737
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 15852
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 10222
7 EXHIBIT 32.2 ex32_2.htm EX-32.2 9919
  Complete submission text file 0001140361-13-013730.txt   15140188

Data Files

Seq Description Document Type Size
8 INSTANCE DOCUMENT rnn-20121231.xml EX-101.INS 3100593
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnn-20121231.xsd EX-101.SCH 81779
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rnn-20121231_cal.xml EX-101.CAL 42284
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rnn-20121231_def.xml EX-101.DEF 186541
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnn-20121231_lab.xml EX-101.LAB 493532
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnn-20121231_pre.xml EX-101.PRE 408234
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34079 | Film No.: 13711515
SIC: 2834 Pharmaceutical Preparations